Risk for Hepatocellular Carcinoma After Hepatitis C Virus Antiviral Therapy With Direct-Acting Antivirals: Case Closed?

被引：12
|
作者：
Maan, Raoel [1 ]
Feld, Jordan J. [2 ]
机构：
[1] Univ Med Ctr Rotterdam, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Univ Toronto, Toronto Ctr Liver Dis, Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada
来源：
GASTROENTEROLOGY | 2017年 / 153卷 / 04期
关键词：
SUSTAINED VIROLOGICAL RESPONSE; ALL-CAUSE MORTALITY; REDUCES RISK; LIVER; RECURRENCE; INFECTION; CANCER;
D O I：
10.1053/j.gastro.2017.08.052
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：890 / 892
页数：3
相关论文
共 50 条
  • [1] The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma
    Chinchilla-Lopez, Paulina
    Qi, Xingshun
    Yoshida, Eric M.
    Mendez-Sanchez, Nahum
    ANNALS OF HEPATOLOGY, 2017, 16 (03) : 328 - 330
  • [2] The Impact of Direct-acting Antiviral Therapy for Hepatitis C on Hepatocellular Carcinoma Risk
    Feng Su
    George N. Ioannou
    Current Hepatology Reports, 2018, 17 (4) : 377 - 384
  • [3] Patients with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for hepatitis C virus
    Guardigni, Viola
    Toschi, Alice
    Badia, Lorenzo
    Del Turco, Elena Rosselli
    Salsi, Eleonora
    Cristini, Francesco
    Sighinolfi, Laura
    Fabbri, Gabriele
    Massari, Marco
    Cuomo, Gianluca
    Viale, Pierluigi
    Verucchi, Gabriella
    AIDS, 2021, 35 (12) : 1967 - 1972
  • [4] Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end
    Muzica, Cristina Maria
    Stanciu, Carol
    Huiban, Laura
    Singeap, Ana-Maria
    Sfarti, Catalin
    Zenovia, Sebastian
    Cojocariu, Camelia
    Trifan, Anca
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (43) : 6770 - 6781
  • [5] Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end
    Cristina Maria Muzica
    Carol Stanciu
    Laura Huiban
    Ana-Maria Singeap
    Catalin Sfarti
    Sebastian Zenovia
    Camelia Cojocariu
    Anca Trifan
    World Journal of Gastroenterology, 2020, (43) : 6770 - 6781
  • [6] Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals
    Prenner, Stacey B.
    VanWagner, Lisa B.
    Flamm, Steven L.
    Salem, Riad
    Lewandowski, Robert J.
    Kulik, Laura
    JOURNAL OF HEPATOLOGY, 2017, 66 (06) : 1173 - 1181
  • [7] Risk of hepatocellular carcinoma and efficacy of direct-acting antivirals in patients with concurrent hepatitis C virus
    Harrod, Elizabeth
    Agarwal, Ritu
    Tabrizian, Parissa
    Rayapudi, Madhavi
    Ala, Aftab
    Fiel, Isabel
    Schwartz, Myron
    Dieterich, Douglas
    Friedman, Scott
    Saberi, Behnam
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E733 - E734
  • [8] Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction?
    Hsu, Shih-Jer
    Yang, Sheng-Shun
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (01) : 3 - 11
  • [9] Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals
    Fiehn, Felix
    Beisel, Claudia
    Binder, Marco
    CURRENT OPINION IN VIROLOGY, 2024, 67
  • [10] No difference between direct-acting antivirals for hepatitis C in hepatocellular carcinoma risk
    Mun, Elijah J.
    Green, Pamela
    Berry, Kristin
    Ioannou, George N.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (01) : 47 - 52
12345